Statistics

Total Visits

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial136

File Visits

Downloads
36218-371.pdf57

Select a period of time:

Number of views in the range

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial49

Number of downloads in the range

Downloads
36218-371.pdf24

Views

Views
December 20253
January 202622
February 20260
March 20268
April 20264
May 20269
June 20263
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • December 2025
    4
  • January 2026
    6
  • February 2026
    0
  • March 2026
    1
  • April 2026
    5
  • May 2026
    4
  • June 2026
    4
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States30
Mexico4
United Kingdom2
Netherlands2
Canada2
Argentina1
Colombia1
Algeria1
Finland1
Panama1
 

Top countries by downloads

Downloads
United States9
Algeria2
Netherlands1
Argentina1
Mexico1
 

Top cities views

Views
San Jose16
Santa Clara2
Groningen2
Ashburn1
Barquisimeto1
Caucete1
Ciudad Victoria1
Cleveland1
Constantine1
Dakar1
 

Top cities by downloads

Downloads
Constantine1